Sleep Apnea Devices Global Market-Forecast to 2026

Publishing Date : June, 2020
Report Code : HCMD0170
Price:
Single license $4,950
Site license $6,750
Global license $9,000


Note: The report would be dispatched after confirmation of payment

Sleep apnea is a serious disorder that occurs when breathing is interrupted during sleep, this happens, when the upper airway becomes repeatedly blocked and preventing the brain and lungs from getting enough oxygen, resulting in heavy snoring and choking. Patients are affected by different types of sleep apnea, such as obstructive sleep apnea (OSA) caused by the blockage of the airway, when the muscle in the back of the throat collapses during sleep, central sleep apnea (CSA), caused when the brain fails to send the signal to the muscle to breathe, due to instability in the respiratory control center and complex sleep apnea syndrome a mixture of OSA and CSA, that central sleep apnea may emerge during titration of CPAP in patients with obstructive sleep apnea. Sleep apnea may cause due to physical structure or certain medical conditions such as obesity, large tonsils, endocrine disorders, neuromuscular disorders, certain genetic syndrome and premature birth.

The Sleep apnea devices global market is expected to grow at high single digit CAGR from 2019 to 2026 to reach $8,173.8 million by 2026. The increase in the rate of sleep apnea population, increasing lifestyle changes that causing poor sleep patterns elevated rates of stress, obesity and cardiovascular disease and increasing funding and investment in patient monitoring are driving the market growth. However, the alternative therapies of sleep apnea, stringent regulatory requirements for product approvals and non-compliances of patients with PAP devices are restraining the market growth.

The Sleep apnea devices market segmented based on products, application, end-users and geography. The product market is segmented into diagnostic devices and treatment devices. According to IQ4I research, treatment devices accounted for the largest revenue in 2019 and expected to grow at high single digit CAGR from 2019 to 2026. The diagnostic devices segment is expected to grow at a mid-single digit CAGR from 2019 to 2026 due to increasing diagnosis rate of sleep apnea and increasing connectivity of rural areas.

The sleep apnea diagnostic devices market is further classified into in-lab sleep test and home sleep test. Among these, the in-lab sleep test accounted for the largest revenue in 2019 and the market is expected to grow at a mid-single digit CAGR from 2019 to 2026. Based on products, in – lab sleep test is further segmented into attended polysomnography (PSG), Respiratory polygraph and pulse oximeter. Among them, attended polysomnography segment held the largest revenue in 2019 of the market and the market is expected to grow at a high single digit CAGR from 2019 to 2026. Increasing incidence of obstructive sleep apnea, increasing demand for gold standard polysomnography devices are the factors driving the market growth. The home sleep test is further segmented into unattended polysomnography, Actigraphy and others, among these; unattended polysomnography segment accounted for the largest revenue in 2019 and the market is expected to grow at mid-single digit CAGR of from 2019 to 2026.

The sleep apnea treatment devices market is segmented into PAP devices, oral appliances, phrenic nerve stimulators, hypoglossal nerve stimulator and others. Among them, the PAP devices segment commanded the largest revenue in 2019 and the market is expected to grow at high single digit CAGR from 2019 to 2026. Increasing the incidence of sleep apnea disorder and increasing the use of PAP devices are the factors driving the market. The hypoglossal nerve stimulator is expected to grow at high teen CAGR from 2019 to 2026. PAP devices are further segmented into CPAP, APAP, BiPAP, ASV and accessories, among these, Accessories accounted for the largest revenue in 2019 and expected to grow at mid-single digit CAGR from 2019 to 2026, APAP devices segment is expected to grow at double digit CAGR from 2019 to 2026. An oral appliance segment is further segmented into Mandibular repositioning devices (MRD) and Tongue retaining devices (TRD), among these, MRD accounted for the largest revenue in 2019 and the market is expected to grow at mid-single digit CAGR from 2019 to 2026, due to increased use wearable devices. Accessories are further segmented into full face masks, nasal masks, nasal pillow masks and others, among these, the full face masks segmented is accounted for the largest revenue in 2019 and the market is expected to grow at double digit CAGR from 2019 to 2026.

The sleep apnea application market is segmented into obstructive sleep apnea (OSA), central sleep apnea (CSA) and complex sleep apnea syndrome (ComSAS). Among these, OSA accounted for the largest revenue in 2019 and the market is expected to grow at high single digit CAGR from 2019 to 2026.

The Sleep apnea devices global market based on end-user is segmented into hospitals, sleep centers, home healthcare and others. Among these, the sleep centers segment accounted for the largest revenue in 2019 and the market is expected to grow at high single digit from 2019 to 2026. The homecare market is expected to be the fastest-growing segment with high single digit CAGR from 2019 to 2026 due to the improvement and acceptance of home care devices has increased.

The Sleep apnea devices global market based on geography is segmented into North America, Europe, Asia – Pacific and Rest of the World, among these, North America accounted for the largest revenue of $2,365.1 million in 2019 and the market is expected to grow at a CAGR of high single digit from 2019 to 2026. Increasing awareness about the diseases complications in developed countries, high investments in healthcare infrastructures and demand for quality services are propelling the market growth. Asia – Pacific is expected to grow at a double digit CAGR from 2019 to 2026 due to increasing awareness about the health in emerging countries.

Major players in Sleep apnea devices global market are ResMed Inc. (U.S.), Koninklijke Philips N.V. (Netherlands), Fisher and Paykel Healthcare Corporation Ltd., (New Zealand), Apex Medical Corporation (Taiwan), Nihon Kohden Corporation (Japan) Natus Medical Inc.. (U.S.), Inspire Medical Inc. (U.S.), Drive Medical (Drive DeVilbiss Healthcare) (U.S.), and SomnoMed (U.S.).

The report provides an in-depth market analysis of the above-mentioned segments across the following regions:

  • North America
  • U.S.
  • Rest of North America
  • Europe
  • Germany
  • U.K.
  • France
  • Rest of Europe
  • Asia-Pacific 
  • Japan
  • China
  • India
  • Rest of APAC
  • Rest of the World (RoW)
  • Brazil
  • Rest of Latin America
  • Middle East and Others
  • 1     EXECUTIVE SUMMARY
  • 2     INTRODUCTION
    • 2.1     KEY TAKEAWAYS
    • 2.2     SCOPE OF THE REPORT
    • 2.3     REPORT DESCRIPTION
    • 2.4     MARKETS COVERED
    • 2.5     STAKEHOLDERS
    • 2.6     RESEARCH METHODOLOGY
      • 2.6.1     MARKET SIZE ESTIMATION
      • 2.6.2     MARKET BREAKDOWN AND DATA TRIANGULATION
      • 2.6.3     SECONDARY SOURCES
      • 2.6.4     PRIMARY SOURCES
      • 2.6.5     KEY DATA POINTS FROM SECONDARY SOURCES
      • 2.6.6     KEY DATA POINTS FROM PRIMARY SOURCES
      • 2.6.7     ASSUMPTIONS
  • 3     MARKET ANALYSIS
    • 3.1     INTRODUCTION
    • 3.2     MARKET SEGMENTATION
    • 3.3     FACTORS INFLUENCING MARKET
      • 3.3.1     DRIVERS AND OPPORTUNITIES
        • 3.3.1.1     THE INCREASING RATE OF SLEEP APNEA POPULATION
        • 3.3.1.2     INCREASING LIFESTYLE CHANGES THAT CAUSING POOR SLEEP PATTERNS ELEVATED RATES OF STRESS, OBESITY AND CARDIOVASCULAR DISEASE
        • 3.3.1.3     FAVORABLE REIMBURSEMENT POLICIES
        • 3.3.1.4     TECHNOLOGICAL ADVANCEMENTS
      • 3.3.2     RESTRAINTS AND THREATS
        • 3.3.2.1     ALTERNATIVE THERAPIES OF SLEEP APNEA
        • 3.3.2.2     NON-COMPLIANCES OF PATIENTS WITH PAP DEVICES
        • 3.3.2.3     LACK OF AWARENESS ABOUT SLEEP APNEA DISORDER
        • 3.3.2.4     STRINGENT REGULATORY REQUIREMENTS FOR NEW PRODUCTS
    • 3.4     REGULATORY AFFAIRS
      • 3.4.1     INTERNATIONAL ORGANIZATION FOR STANDARDIZATION
        • 3.4.1.1     ISO 9001: 2015 QUALITY MANAGEMENT SYSTEM
        • 3.4.1.2     ISO 13485 MEDICAL DEVICES
      • 3.4.2     THE U.S.
      • 3.4.3     CANADA
      • 3.4.4     EUROPE
      • 3.4.5     INDIA
      • 3.4.6     CHINA
      • 3.4.7     JAPAN
    • 3.5     TECHNOLOGICAL ADVANCEMENTS
      • 3.5.1     INTRODUCTION
      • 3.5.2     ARTIFICIAL INTELLIGENCE IN SLEEP APNEA DIAGNOSIS AND TREATMENT
      • 3.5.3     MAGNAP TREATMENT FOR SLEEP APNEA
      • 3.5.4     SMART PAP DEVICES
      • 3.5.5     3D IMAGING THE NEW TREATMENT TECHNIQUES FOR OBSTRUCTIVE SLEEP APNEA
      • 3.5.6     WEARABLE PATCH DEVICES TO DETECT SLEEP APNEA
      • 3.5.7     SLEEP TELEMEDICINE IN DIAGNOSIS AND TREATMENT OF SLEEP APNEA
      • 3.5.8     REMOTE MONITORING IN SLEEP APNEA MANAGEMENT AND PAP ADHERENCE
    • 3.6     PORTER’S FIVE FORCE ANALYSIS
      • 3.6.1     THREAT OF NEW ENTRANTS
      • 3.6.2     THREAT OF SUBSTITUTES
      • 3.6.3     COMPETITIVE RIVALRY
      • 3.6.4     BARGAINING POWER OF SUPPLIERS
      • 3.6.5     BARGAINING POWER OF BUYERS
    • 3.7     SUPPLY CHAIN ANALYSIS
    • 3.8     MARKET SHARE ANALYSIS BY MAJOR PLAYERS
      • 3.8.1     SLEEP APNEA DEVICES MARKET SHARE ANALYSIS
      • 3.8.2     POLYSOMNOGRAPHY MARKET SHARE ANALYSIS
      • 3.8.3     CPAP DEVICES MARKET SHARE ANALYSIS
      • 3.8.4     APAP DEVICES MARKET SHARE ANALYSIS
      • 3.8.5     BPAP MARKET SHARE ANALYSIS
    • 3.9     CLINICAL TRIALS
    • 3.1     SLEEP APNEA PRODUCT APPROVALS AND NEW PRODUCT LAUNCH
    • 3.11     SLEEP APNEA DEVICES-DEALS
    • 3.12     FUNDING SCENARIO
    • 3.13     REIMBURSEMENT SCENARIO
    • 3.14     SLEEP APNEA DEVICES UNITS SOLD, INSTALLED BASE AND MARKET PENETRATION
  • 4     SLEEP APNEA DEVICES GLOBAL MARKET, BY PRODUCT
    • 4.1     INTRODUCTION
    • 4.2     SLEEP APNEA DIAGNOSTIC DEVICES
      • 4.2.1     IN-LAB SLEEP TEST
        • 4.2.1.1     ATTENDED POLYSOMNOGRAPHY
        • 4.2.1.2     RESPIRATORY POLYGRAPH
        • 4.2.1.3     PULSE OXIMETER
      • 4.2.2     HOME SLEEP TEST
        • 4.2.2.1     UNATTENDED POLYSOMNOGRAPHY
        • 4.2.2.2     ACTIGRAPHY
        • 4.2.2.3     OTHERS
    • 4.3     SLEEP APNEA TREATMENT DEVICES
      • 4.3.1     POSITIVE AIRWAY PRESSURE DEVICES (PAP) AND ACCESSORIES
        • 4.3.1.1     CONTINUOUS PAP DEVICES (CPAP)
        • 4.3.1.2     AUTOMATIC PAP (APAP) DEVICES
        • 4.3.1.3     BI-LEVEL PAP (BPAP) DEVICES
        • 4.3.1.4     ADAPTIVE SERVO-VENTILATOR (ASV)
        • 4.3.1.5     ACCESSORIES
          • 4.3.1.5.1     FULL FACE MASK
          • 4.3.1.5.2     NASAL MASKS
          • 4.3.1.5.3     NASAL PILLOW MASKS
          • 4.3.1.5.4     OTHER MASKS
      • 4.3.2     ORAL APPLIANCES
      • 4.3.3     MANDIBULAR REPOSITIONING DEVICE
      • 4.3.4     TONGUE RETAINING DEVICES
      • 4.3.5     PHRENIC NERVE STIMULATION (PNS)
      • 4.3.6     HYPOGLOSSAL NERVE STIMULATION (HGNS)
      • 4.3.7     OTHER SLEEP THERAPEUTIC DEVICES
  • 5     SLEEP APNEA DEVICES GLOBAL MARKET, BY APPLICATION
    • 5.1     INTRODUCTION
    • 5.2     OBSTRUCTIVE SLEEP APNEA (OSA)
    • 5.3     CENTRAL SLEEP APNEA (CSA)
    • 5.4     COMPLEX SLEEP APNEA
  • 6     SLEEP APNEA DEVICES GLOBAL MARKET, BY END-USERS
    • 6.1     INTRODUCTION
    • 6.2     HOSPITALS
    • 6.3     SLEEP CENTERS
    • 6.4     HOME HEALTHCARE
    • 6.5     OTHERS
  • 7     SLEEP APNEA DEVICES MARKET BY REGION
    • 7.1     INTRODUCTION
    • 7.2     NORTH AMERICA
      • 7.2.1     U.S.
      • 7.2.2     REST OF NORTH AMERICA
    • 7.3     EUROPE
      • 7.3.1     GERMANY
      • 7.3.2     U.K.
      • 7.3.3     FRANCE
      • 7.3.4     REST OF EUROPE
    • 7.4     APAC
      • 7.4.1     JAPAN
      • 7.4.2     CHINA
      • 7.4.3     INDIA
      • 7.4.4     REST OF APAC
    • 7.5     ROW
      • 7.5.1     BRAZIL
      • 7.5.2     REST OF LATAM
      • 7.5.3     MIDDLE EAST AND OTHERS
  • 8     COMPETITIVE LANDSCAPE
    • 8.1     INTRODUCTION
    • 8.2     NEW PRODUCT LAUNCH
    • 8.3     APPROVALS
    • 8.4     AGREEMENTS
    • 8.5     ACQUISITION
    • 8.6     OTHERS
  • 9     MAJOR COMPANIES
    • 9.1     APEX MEDICAL CORPORATION
      • 9.1.1     OVERVIEW
      • 9.1.2     FINANCIALS
      • 9.1.3     PRODUCT PORTFOLIO
      • 9.1.4     KEY DEVELOPMENTS
      • 9.1.5     BUSINESS STRATEGY
      • 9.1.6     SWOT ANALYSIS
    • 9.2     DRIVE MEDICAL (DRIVE DEVILBISS HEALTHCARE).
      • 9.2.1     OVERVIEW
      • 9.2.2     FINANCIALS
      • 9.2.3     PRODUCT PORTFOLIO
      • 9.2.4     KEY DEVELOPMENTS
      • 9.2.5     BUSINESS STRATEGY
      • 9.2.6     SWOT ANALYSIS
    • 9.3     FISHER AND PAYKEL HEALTHCARE CORPORATION LIMITED
      • 9.3.1     OVERVIEW
      • 9.3.2     FINANCIALS
      • 9.3.3     PRODUCT PORTFOLIO
      • 9.3.4     KEY DEVELOPMENTS
      • 9.3.5     BUSINESS STRATEGY
      • 9.3.6     SWOT ANALYSIS
    • 9.4     INSPIRE MEDICAL SYSTEMS INC.
      • 9.4.1     OVERVIEW
      • 9.4.2     FINANCIALS
      • 9.4.3     PRODUCT PORTFOLIO
      • 9.4.4     KEY DEVELOPMENTS
      • 9.4.5     BUSINESS STRATEGY
      • 9.4.6     SWOT ANALYSIS
    • 9.5     KONINKLIJKE PHILIPS N.V.
      • 9.5.1     OVERVIEW
      • 9.5.2     FINANCIALS
      • 9.5.3     PRODUCT PORTFOLIO
      • 9.5.4     KEY DEVELOPMENTS
      • 9.5.5     BUSINESS STRATEGY
      • 9.5.6     SWOT ANALYSIS
    • 9.6     NATUS MEDICAL INCORPORATED.
      • 9.6.1     OVERVIEW
      • 9.6.2     FINANCIALS
      • 9.6.3     PRODUCT PORTFOLIO
      • 9.6.4     KEY DEVELOPMENTS
      • 9.6.5     BUSINESS STRATEGY
      • 9.6.6     SWOT ANALYSIS
    • 9.7     NIHON KOHDEN CORPORATION.
      • 9.7.1     OVERVIEW
      • 9.7.2     FINANCIALS
      • 9.7.3     PRODUCT PORTFOLIO
      • 9.7.4     KEY DEVELOPMENTS
      • 9.7.5     BUSINESS STRATEGY
      • 9.7.6     SWOT ANALYSIS
    • 9.8     RESMED INC.
      • 9.8.1     OVERVIEW
      • 9.8.2     FINANCIALS
      • 9.8.3     PRODUCT PORTFOLIO
      • 9.8.4     KEY DEVELOPMENTS
      • 9.8.5     BUSINESS STRATEGY
      • 9.8.6     SWOT ANALYSIS
    • 9.9     SOMNOMED
      • 9.9.1     OVERVIEW
      • 9.9.2     FINANCIALS
      • 9.9.3     PRODUCT PORTFOLIO
      • 9.9.4     KEY DEVELOPMENTS
      • 9.9.5     BUSINESS STRATEGY
      • 9.9.6     SWOT ANALYSIS
    • 9.10     VYAIRE MEDICAL, INC
      • 9.10.1     OVERVIEW
      • 9.10.2     FINANCIALS
      • 9.10.3     PRODUCT PORTFOLIO
      • 9.10.4     KEY DEVELOPMENTS
      • 9.10.5     BUSINESS STRATEGY
      • 9.10.6     SWOT ANALYSIS

      LIST OF TABLES

      • TABLE 1     SLEEP APNEA DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 2     SLEEP APNEA DEVICES GLOBAL MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 3     DIAGNOSTIC DEVICES GLOBAL MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 4     IN-LAB SLEEP TEST GLOBAL MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 5     ATTENDED POLYSOMNOGRAPHY GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 6     RESPIRATORY POLYGRAPH GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 7     PULSE OXIMETER GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 8     HOME SLEEP TEST GLOBAL MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 9     HOME SLEEP TEST GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 10     UNATTENDED POLYSOMNOGRAPHY GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 11     ACTIGRAPHY GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 12     OTHERS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 13     TREATMENT DEVICES GLOBAL MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 14     PAP DEVICES GLOBAL MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 15     PAP DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 16     CPAP DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 17     APAP DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 18     BIPAP DEVCES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 19     ADAPTIVE SERVO-VENTILATOR (ASV) GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 20     ACCESSORIES GLOBAL MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 21     ACCESSORIES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 22     FULL FACE MASKS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 23     NASAL MASKS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 24     NASAL PILLOW MASKS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 25     OTHER MASKS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 26     ORAL APPLIANCES GLOBAL MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 27     ORAL APPLIANCES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 28     MANDIBULAR REPOSITIONING DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 29     TONGUE RETAINING DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 30     PHRENIC NERVE STIMULATOR GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 31     HYPOGLOSSAL NERVE STIMULATOR GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 32     OTHERS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 33     SLEEP APNEA DEVICES GLOBAL MARKET REVENUE, BY APLLICATION, (2018-2026) ($MN)
      • TABLE 34     OBSTRUCTIVE SLEEP APNEA DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 35     CENTRAL SLEEP APNEA DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 36     COMPLEX SLEEP APNEA DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 37     SLEEP APNEA DEVICES GLOBAL MARKET REVENUE, BY END-USERS, (2018-2026) ($MN)
      • TABLE 38     HOSPITAL GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 39     SLEEP CENTERS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 40     HOME HEALTHCARE GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 41     OTHER END-USER GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 42     SLEEP APNEA DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 43     NORTH AMERICA SLEEP APNEA DEVICES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 44     NORTH AMERICA DIAGNOSTIC DEVICES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 45     NORTH AMERICA IN-LAB SLEEP TEST MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 46     NORTH AMERICA HOME SLEEP TEST MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 47     NORTH AMERICA TREATMENT DEVICES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 48     NORTH AMERICA PAP DEVICES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 49     NORTH AMERICA ACCESSORIES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 50     NORTH AMERICA ORAL APPLIANCES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 51     NORTH AMERICA SLEEP APNEA DEVICES MARKET REVENUE, BY APPLICATION, (2018-2026) ($MN)
      • TABLE 52     NORTH AMERICA SLEEP APNEA DEVICES MARKET REVENUE, BY END-USER, (2018-2026) ($MN)
      • TABLE 53     NORTH AMERICA SLEEP APNEA DEVICES MARKET REVENUE, BY COUNTRY, (2018-2026) ($MN)
      • TABLE 54     EUROPE SLEEP APNEA DEVICES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 55     EUROPE DIAGNOSTIC DEVICES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 56     EUROPE IN-LAB SLEEP TEST MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 57     EUROPE HOME SLEEP TEST MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 58     EUROPE TREATMENT DEVICES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 59     EUROPE PAP DEVICES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 60     EUROPE ACCESSORIES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 61     EUROPE ORAL APPLIANCES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 62     EUROPE SLEEP APNEA DEVICES MARKET REVENUE, BY APPLICATION, (2018-2026) ($MN)
      • TABLE 63     EUROPE SLEEP APNEA DEVICES MARKET REVENUE, BY END-USER, (2018-2026) ($MN)
      • TABLE 64     EUROPE SLEEP APNEA DEVICES MARKET REVENUE, BY COUNTRY, (2018-2026) ($MN)
      • TABLE 65     APAC SLEEP APNEA DEVICES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 66     APAC DIAGNOSTIC DEVICES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 67     APAC IN-LAB SLEEP TEST MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 68     APAC HOME SLEEP TEST MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 69     APAC TREATMENT DEVICES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 70     APAC PAP DEVICES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 71     APAC ACCESSORIES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 72     APAC ORAL APPLIANCES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 73     APAC SLEEP APNEA DEVICES MARKET REVENUE, BY APPLICATION, (2018-2026) ($MN)
      • TABLE 74     APAC SLEEP APNEA DEVICES MARKET REVENUE, BY END-USER, (2018-2026) ($MN)
      • TABLE 75     APAC SLEEP APNEA DEVICES MARKET REVENUE, BY COUNTRY, (2018-2026) ($MN)
      • TABLE 76     ROW SLEEP APNEA DEVICES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 77     ROW DIAGNOSTIC DEVICES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 78     ROW IN-LAB SLEEP TEST MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 79     ROW HOME SLEEP TEST MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 80     ROW TREATMENT DEVICES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 81     ROW PAP DEVICES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 82     ROW ACCESSORIES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 83     ROW ORAL APPLIANCES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 84     ROW SLEEP APNEA DEVICES MARKET REVENUE, BY APPLICATION, (2018-2026) ($MN)
      • TABLE 85     ROW SLEEP APNEA DEVICES MARKET REVENUE, BY END-USER, (2018-2026) ($MN)
      • TABLE 86     ROW SLEEP APNEA DEVICES MARKET REVENUE, BY COUNTRY, (2018-2026) ($MN)
      • TABLE 87     NEW PRODUCT LAUNCH (2018-2019)
      • TABLE 88     APPROVALS (2018-2019)
      • TABLE 89     AGREEMENTS (2018-2019)
      • TABLE 90     ACQUISITION (2018-2019)
      • TABLE 91     OTHERS (2018-2019)
      • TABLE 92     APEX MEDICAL CORPORATION TOTAL REVENUE AND R&D EXPENSES, (2017-2019) ($MN)
      • TABLE 93     FISHER AND PAYKEL TOTAL REVENUE AND R&D EXPENSES, (2017-2019) (Q2) ($MN)
      • TABLE 94     FISHER AND PAYKEL TOTAL REVENUE, BY PRODUCTS, (2017-2019) (Q2) ($MN)
      • TABLE 95     FISHER AND PAYKEL TOTAL REVENUE, BY GEOGRAPHY, (2017-2019) ($MN)
      • TABLE 96     INSPIRE MEDICAL SYSTEMS INC.: TOTAL REVENUE AND R&D EXPENSES (2017-2019) ($MN)
      • TABLE 97     INSPIRE MEDICAL SYSTEMS INC.: TOTAL REVENUE, BY GEOGRAPHY (2017-2019) ($MN)
      • TABLE 98     KONINKLIJKE PHILIPS N.V.: TOTAL REVENUE AND R&D EXPENSES, (2017-2019) ($MN)
      • TABLE 99     KONINKLIJKE PHILIPS N.V.: TOTAL REVENUE, BY SEGMENTS, (2017-2019) ($MN)
      • TABLE 100     KONINKLIJKE PHILIPS N.V.: TOTAL REVENUE, BY GEOGRAPHY, (2017-2019) ($MN)
      • TABLE 101     NATUS MEDICAL INCORPORATED: TOTAL REVENUE AND R&D EXPENSES (2017-2019) ($MN)
      • TABLE 102     NATUS MEDICAL CORPORATION: TOTAL REVENUE, BY SEGMENTS (2017-2019) ($MN)
      • TABLE 103     NATUS MEDICAL CORPORATION: TOTAL REVENUE, BY NEURO SEGMENT (2017-2019)($MN)
      • TABLE 104     NATUS MEDICAL CORPORATION: TOTAL REVENUE, BY REGION (2017-2019)($MN)
      • TABLE 105     NIHON KOHDEN: TOTAL REVENUE AND R&D EXPENSES (2017-2019) (Q3) ($MN)
      • TABLE 106     NIHON KOHDEN: TOTAL REVENUE, BY BUSINESS SEGMENTS (2017-2019) (Q3) ($MN)
      • TABLE 107     NIHON KOHDEN: TOTAL REVENUE, BY GEOGRAPHY (2017-2019) (Q3) ($MN)
      • TABLE 108     RESMED INC.: TOTAL REVENUE AND R&D EXPENSES, (2018-2020) (Q2) ($MN)
      • TABLE 109     RESMED INC.: TOTAL REVENUE, BY GEOGRAPHY, (2018-2020) (Q2) ($MN)
      • TABLE 110     RESMED INC.: TOTAL REVENUE, BY GEOGRAPHY, (2018-2020) (Q2) ($MN)

      LIST OF FIGURES

      • FIGURE 1     SLEEP APNEA DEVICES GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
      • FIGURE 2     RESEARCH METHODOLOGY: SLEEP APNEA DEVICES GLOBAL MARKET
      • FIGURE 3     SLEEP APNEA DEVICES GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
      • FIGURE 4     SLEEP APNEA DEVICES GLOBAL MARKET: FORECASTING MODEL
      • FIGURE 5     SLEEP APNEA DEVICES GLOBAL MARKET: MARKET BREAKDOWN AND DATA TRIANGULATION
      • FIGURE 6     SLEEP APNEA DEVICES GLOBAL MARKET SEGMENTATION
      • FIGURE 7     MARKET DYNAMICS
      • FIGURE 8     SLEEP APNEA DEVICES GLOBAL MARKET: PORTER’S ANALYSIS
      • FIGURE 9     SLEEP APNEA DEVICES GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
      • FIGURE 10     SLEEP APNEA DEVICES MARKET SHARE ANALYSIS BY MAJOR PLAYERS, 2019 (%)
      • FIGURE 11     POLYSOMNOGRAPHY MARKET SHARE ANALYSIS BY MAJOR PLAYERS, 2019 (%)
      • FIGURE 12     CPAP DEVICES MARKET SHARE ANALYSIS BY MAJOR PLAYERS, 2019 (%)
      • FIGURE 13     APAP DEVICES MARKET SHARE ANALYSIS BY MAJOR PLAYERS, 2019 (%)
      • FIGURE 14     BPAP MARKET SHARE, BY KEY PLAYERS, 2019 (%)
      • FIGURE 15     GLOBAL PAP DEVICES PENETRATION, (2019)
      • FIGURE 16     GLOBAL ORAL APPLIANCES PENETRATION, (2019)
      • FIGURE 17     SLEEP APNEA DEVICES GLOBAL MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
      • FIGURE 18     DIAGNOSTIC DEVICES GLOBAL MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
      • FIGURE 19     IN-LAB SLEEP TEST GLOBAL MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
      • FIGURE 20     HOME SLEEP TEST GLOBAL MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
      • FIGURE 21     TREATMENT DEVICES GLOBAL MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
      • FIGURE 22     PAP DEVICES GLOBAL MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
      • FIGURE 23     ACCESSORIES GLOBAL MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
      • FIGURE 24     ORAL APPLIANCES GLOBAL MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
      • FIGURE 25     SLEEP APNEA DEVICES GLOBAL MARKET SHARE, BY APPLICATION (2019 V/S 2026) (%)
      • FIGURE 26     SLEEP APNEA DEVICES GLOBAL MARKET SHARE, BY END-USERS (2019 V/S 2026) (%)
      • FIGURE 27     SLEEP APNEA DEVICES GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN), CAGR (%)
      • FIGURE 28     SLEEP APNEA DEVICES GLOBAL MARKET SHARE BY REGION AND MARKET REVENUE BY COUNTRY, (2019) (%) ($MN)
      • FIGURE 29     NORTH AMERICA SLEEP APNEA DEVICES MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
      • FIGURE 30     NORTH AMERICA DIAGNOSTIC DEVICES MARKET SHARE, BY PRODUCT (2018 V/S 2026) (%)
      • FIGURE 31     NORTH AMERICA IN-LAB SLEEP TEST MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
      • FIGURE 32     NORTH AMERICA HOME SLEEP TEST MARKET SHARE, BY PRODUCT, (2019 V/S 2026) (%)
      • FIGURE 33     NORTH AMERICA TREATMENT DEVICES MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
      • FIGURE 34     NORTH AMERICA PAP DEVICE AND ACCESSORIES MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
      • FIGURE 35     NORTH AMERICA ACCESSORIES MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
      • FIGURE 36     NORTH AMERICA ORAL APPLIANCES MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
      • FIGURE 37     NORTH AMERICA SLEEP APNEA DEVICES MARKET SHARE, BY APPLICATION (2019 V/S 2026) (%)
      • FIGURE 38     NORTH AMERICA SLEEP APNEA DEVICES MARKET SHARE, BY END-USER (2019 V/S 2026) (%)
      • FIGURE 39     NORTH AMERICA SLEEP APNEA DEVICES MARKET SHARE, BY COUNTRY (2019 V/S 2026) (%)
      • FIGURE 40     NORTH AMERICA PAP MARKET PENETRATION, (2019)
      • FIGURE 41     NORTH AMERICA ORAL APPLIANCES PENETRATION, (2019)
      • FIGURE 42     U.S. SLEEP APNEA DEVICES, DIAGNOSTIC DEVICES, IN-LAB SLEEP TEST AND HOME SLEEP TEST MARKET REVENUE, BY PRODUCT, (2019 V/S 2026) ($MN)
      • FIGURE 43     U.S. TREATMENT DEVICES MARKET REVENUE, BY PRODUCTS, (2019 V/S 2026) ($MN)
      • FIGURE 44     U.S. SLEEP APNEA DEVICES MARKET REVENUE, BY APPLICATION (2019 V/S 2026) ($MN)
      • FIGURE 45     U.S. SLEEP APNEA DEVICES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
      • FIGURE 46     U.S. PAP MARKET PENETRATION, (2019)
      • FIGURE 47     U.S. ORAL APPLIANCES PENETRATION, (2019)
      • FIGURE 48     REST OF N.A. SLEEP APNEA DEVICES, DIAGNOSTIC DEVICES, IN-LAB SLEEP TEST AND HOME SLEEP TEST MARKET REVENUE, BY PRODUCT, (2019 V/S 2026) ($MN)
      • FIGURE 49     REST OF N.A. TREATMENT DEVICES MARKET REVENUE, BY PRODUCTS, (2019 V/S 2026) ($MN)
      • FIGURE 50     REST OF N.A SLEEP APNEA DEVICES MARKET REVENUE, BY APPLICATION (2019 V/S 2026) ($MN)
      • FIGURE 51     REST OF N.A SLEEP APNEA DEVICES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
      • FIGURE 52     CANADA PAP MARKET PENETRATION, (2019)
      • FIGURE 53     CANADA ORAL APPLIANCES PENETRATION, (2019)
      • FIGURE 54     MEXICO PAP MARKET PENETRATION, (2019)
      • FIGURE 55     MEXICO ORAL APPLIANCES PENETRATION, (2019)
      • FIGURE 56     EUROPE SLEEP APNEA DEVICES MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
      • FIGURE 57     EUROPE DIAGNOSTIC DEVICES MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
      • FIGURE 58     EUROPE IN-LAB SLEEP TEST MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
      • FIGURE 59     EUROPE HOME SLEEP TEST MARKET SHARE, BY PRODUCT, (2019 V/S 2026) (%)
      • FIGURE 60     EUROPE TREATMENT DEVICES MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
      • FIGURE 61     EUROPE PAP DEVICE MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
      • FIGURE 62     EUROPE ACCESSORIES MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
      • FIGURE 63     EUROPE ORAL APPLIANCES MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
      • FIGURE 64     EUROPE SLEEP APNEA DEVICES MARKET SHARE, BY APPLICATION (2019 V/S 2026) (%)
      • FIGURE 65     EUROPE SLEEP APNEA DEVICES MARKET SHARE, BY END-USER (2019 V/S 2026) (%)
      • FIGURE 66     EUROPE SLEEP APNEA DEVICES MARKET SHARE, BY COUNTRY (2019 V/S 2026) (%)
      • FIGURE 67     EUROPE PAP MARKET PENETRATION, (2019)
      • FIGURE 68     EUROPE ORAL APPLIANCES PENETRATION, (2019)
      • FIGURE 69     GERMANY SLEEP APNEA DEVICES, DIAGNOSTIC DEVICES, IN-LAB SLEEP TEST AND HOME SLEEP TEST MARKET REVENUE, BY PRODUCT, (2019 V/S 2026) ($MN)
      • FIGURE 70     GERMANY TREATMENT DEVICES MARKET REVENUE, BY PRODUCTS, (2019 V/S 2026) ($MN)
      • FIGURE 71     GERMANY SLEEP APNEA DEVICES MARKET REVENUE, BY APPLICATION (2019 V/S 2026) ($MN)
      • FIGURE 72     GERMANY SLEEP APNEA DEVICES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
      • FIGURE 73     GERMANY PAP MARKET PENETRATION, (2019)
      • FIGURE 74     GERMANY ORAL APPLIANCES PENETRATION, (2019)
      • FIGURE 75     U.K SLEEP APNEA DEVICES, DIAGNOSTIC DEVICES, IN-LAB SLEEP TEST AND HOME SLEEP TEST MARKET REVENUE, BY PRODUCT, (2019 V/S 2026) ($MN)
      • FIGURE 76     U.K. TREATMENT DEVICES MARKET REVENUE, BY PRODUCTS, (2019 V/S 2026) ($MN)
      • FIGURE 77     U.K. SLEEP APNEA DEVICES MARKET REVENUE, BY APPLICATION (2019 V/S 2026) ($MN)
      • FIGURE 78     U.K. SLEEP APNEA DEVICES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
      • FIGURE 79     U.K. PAP MARKET PENETRATION, (2019)
      • FIGURE 80     U.K. ORAL APPLIANCES PENETRATION, (2019)
      • FIGURE 81     FRANCE SLEEP APNEA DEVICES, DIAGNOSTIC DEVICES, IN-LAB SLEEP TEST AND HOME SLEEP TEST MARKET REVENUE, BY PRODUCT, (2019 V/S 2026) ($MN)
      • FIGURE 82     FRANCE TREATMENT DEVICES MARKET REVENUE, BY PRODUCTS, (2019 V/S 2026) ($MN)
      • FIGURE 83     FRANCE SLEEP APNEA DEVICES MARKET REVENUE, BY APPLICATION (2019 V/S 2026) ($MN)
      • FIGURE 84     FRANCE SLEEP APNEA DEVICES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
      • FIGURE 85     FRANCE PAP MARKET PENETRATION, (2019)
      • FIGURE 86     FRANCE ORAL APPLIANCES PENETRATION, (2019)
      • FIGURE 87     REST OF E.U. SLEEP APNEA DEVICES, DIAGNOSTIC DEVICES, IN-LAB SLEEP TEST AND HOME SLEEP TEST MARKET REVENUE, BY PRODUCT, (2019 V/S 2026) ($MN)
      • FIGURE 88     REST OF E.U. TREATMENT DEVICES MARKET REVENUE, BY PRODUCTS, (2019 V/S 2026) ($MN)
      • FIGURE 89     REST OF E.U. SLEEP APNEA DEVICES MARKET REVENUE, BY APPLICATION (2019 V/S 2026) ($MN)
      • FIGURE 90     REST OF E.U. SLEEP APNEA DEVICES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
      • FIGURE 91     REST OF E.U. PAP MARKET PENETRATION, (2019)
      • FIGURE 92     REST OF E.U. ORAL APPLIANCES PENETRATION, (2019)
      • FIGURE 93     APAC SLEEP APNEA DEVICES MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
      • FIGURE 94     APAC DIAGNOSTIC DEVICES MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
      • FIGURE 95     APAC IN-LAB SLEEP TEST MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
      • FIGURE 96     APAC HOME SLEEP TEST MARKET SHARE, BY PRODUCT, (2019 V/S 2026) (%)
      • FIGURE 97     APAC TREATMENT DEVICES MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
      • FIGURE 98     APAC PAP DEVICE AND ACCESSORIES MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
      • FIGURE 99     APAC ACCESSORIES MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
      • FIGURE 100     APAC ORAL APPLIANCES MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
      • FIGURE 101     APAC SLEEP APNEA DEVICES MARKET SHARE, BY APPLICATION (2019 V/S 2026) (%)
      • FIGURE 102     APAC SLEEP APNEA DEVICES MARKET SHARE, BY END-USER (2019 V/S 2026) (%)
      • FIGURE 103     APAC SLEEP APNEA DEVICES MARKET SHARE, BY COUNTRY (2019 V/S 2026) (%)
      • FIGURE 104     APAC PAP MARKET PENETRATION, (2019)
      • FIGURE 105     APAC ORAL APPLIANCES PENETRATION, (2019)
      • FIGURE 106     JAPAN SLEEP APNEA DEVICES, DIAGNOSTIC DEVICES, IN-LAB SLEEP TEST AND HOME SLEEP TEST MARKET REVENUE, BY PRODUCT, (2019 V/S 2026) ($MN)
      • FIGURE 107     JAPAN TREATMENT DEVICES MARKET REVENUE, BY PRODUCTS, (2019 V/S 2026) ($MN)
      • FIGURE 108     JAPAN SLEEP APNEA DEVICES MARKET REVENUE, BY APPLICATION (2019 V/S 2026) ($MN)
      • FIGURE 109     JAPAN SLEEP APNEA DEVICES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
      • FIGURE 110     JAPAN PAP MARKET PENETRATION, (2019)
      • FIGURE 111     JAPAM ORAL APPLIANCES PENETRATION, (2019)
      • FIGURE 112     CHINA SLEEP APNEA DEVICES, DIAGNOSTIC DEVICES, IN-LAB SLEEP TEST AND HOME SLEEP TEST MARKET REVENUE, BY PRODUCT, (2019 V/S 2026) ($MN)
      • FIGURE 113     CHINA TREATMENT DEVICES MARKET REVENUE, BY PRODUCTS, (2019 V/S 2026) ($MN)
      • FIGURE 114     CHINA SLEEP APNEA DEVICES MARKET REVENUE, BY APPLICATION (2019 V/S 2026) ($MN)
      • FIGURE 115     CHINA SLEEP APNEA DEVICES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
      • FIGURE 116     CHINA PAP MARKET PENETRATION, (2019)
      • FIGURE 117     CHINA ORAL APPLIANCES PENETRATION, (2019)
      • FIGURE 118     INDIA SLEEP APNEA DEVICES, DIAGNOSTIC DEVICES, IN-LAB SLEEP TEST AND HOME SLEEP TEST MARKET REVENUE, BY PRODUCT, (2019 V/S 2026) ($MN)
      • FIGURE 119     INDIA TREATMENT DEVICES MARKET REVENUE, BY PRODUCTS, (2019 V/S 2026) ($MN)
      • FIGURE 120     INDIA SLEEP APNEA DEVICES MARKET REVENUE, BY APPLICATION (2019 V/S 2026) ($MN)
      • FIGURE 121     INDIA SLEEP APNEA DEVICES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
      • FIGURE 122     INDIA PAP MARKET PENETRATION, (2019)
      • FIGURE 123     INDIA ORAL APPLIANCES PENETRATION, (2019)
      • FIGURE 124     REST OF APAC SLEEP APNEA DEVICES, DIAGNOSTIC DEVICES, IN-LAB SLEEP TEST AND HOME SLEEP TEST MARKET REVENUE, BY PRODUCT, (2019 V/S 2026) ($MN)
      • FIGURE 125     REST OF APAC TREATMENT DEVICES MARKET REVENUE, BY PRODUCTS, (2019 V/S 2026) ($MN)
      • FIGURE 126     REST OF APAC SLEEP APNEA DEVICES MARKET REVENUE, BY APPLICATION (2019 V/S 2026) ($MN)
      • FIGURE 127     REST OF APAC SLEEP APNEA DEVICES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
      • FIGURE 128     REST OF APAC PAP MARKET PENETRATION, (2019)
      • FIGURE 129     REST OF APAC ORAL APPLIANCES PENETRATION, (2019)
      • FIGURE 130     ROW SLEEP APNEA DEVICES MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
      • FIGURE 131     ROW DIAGNOSTIC DEVICES MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
      • FIGURE 132     ROW IN-LAB SLEEP TEST MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
      • FIGURE 133     ROW HOME SLEEP TEST MARKET SHARE, BY PRODUCT, (2019 V/S 2026) (%)
      • FIGURE 134     ROW TREATMENT DEVICES MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
      • FIGURE 135     ROW PAP DEVICE MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
      • FIGURE 136     ROW ACCESSORIES MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
      • FIGURE 137     ROW ORAL APPLIANCES MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
      • FIGURE 138     ROW SLEEP APNEA DEVICES MARKET SHARE, BY APPLICATION (2019 V/S 2026) (%)
      • FIGURE 139     ROW SLEEP APNEA DEVICES MARKET SHARE, BY END-USER (2019 V/S 2026) (%)
      • FIGURE 140     ROW SLEEP APNEA DEVICES MARKET SHARE, BY COUNTRY (2019 V/S 2026) (%)
      • FIGURE 141     ROW PAP MARKET PENETRATION, (2019)
      • FIGURE 142     ROW ORAL APPLIANCES PENETRATION, (2019)
      • FIGURE 143     BRAZIL SLEEP APNEA DEVICES, DIAGNOSTIC DEVICES, IN-LAB SLEEP TEST AND HOME SLEEP TEST MARKET REVENUE, BY PRODUCT, (2019 V/S 2026) ($MN)
      • FIGURE 144     BRAZIL TREATMENT DEVICES MARKET REVENUE, BY PRODUCTS, (2019 V/S 2026) ($MN)
      • FIGURE 145     BRAZIL SLEEP APNEA DEVICES MARKET REVENUE, BY APPLICATION (2019 V/S 2026) ($MN)
      • FIGURE 146     BRAZIL SLEEP APNEA DEVICES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
      • FIGURE 147     BRAZIL PAP MARKET PENETRATION, (2019)
      • FIGURE 148     BRAZIL ORAL APPLIANCES PENETRATION, (2019)
      • FIGURE 149     REST OF LATAM SLEEP APNEA DEVICES, DIAGNOSTIC DEVICES, IN-LAB SLEEP TEST AND HOME SLEEP TEST MARKET REVENUE, BY PRODUCT, (2019 V/S 2026) ($MN)
      • FIGURE 150     REST OF LATAM TREATMENT DEVICES MARKET REVENUE, BY PRODUCTS, (2019 V/S 2026) ($MN)
      • FIGURE 151     REST OF LATAM SLEEP APNEA DEVICES MARKET REVENUE, BY APPLICATION (2019 V/S 2026) ($MN)
      • FIGURE 152     REST OF LATAM SLEEP APNEA DEVICES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
      • FIGURE 153     REST OF LATAM PAP MARKET PENETRATION, (2019)
      • FIGURE 154     REST OF LATAM ORAL APPLIANCES PENETRATION, (2019)
      • FIGURE 155     MIDDLE EAST AND OTHERS SLEEP APNEA DEVICES, DIAGNOSTIC DEVICES, IN-LAB SLEEP TEST AND HOME SLEEP TEST MARKET REVENUE, BY PRODUCT, (2019 V/S 2026) ($MN)
      • FIGURE 156     MIDDLE EAST AND OTHERS TREATMENT DEVICES MARKET REVENUE, BY PRODUCTS, (2019 V/S 2026) ($MN)
      • FIGURE 157     MIDDLE EAST AND OTHERS SLEEP APNEA DEVICES MARKET REVENUE, BY APPLICATION (2019 V/S 2026) ($MN)
      • FIGURE 158     MIDDLE EAST AND OTHERS SLEEP APNEA DEVICES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
      • FIGURE 159     MIDDLE EAST AND OTHERS PAP MARKET PENETRATION, (2019)
      • FIGURE 160     MIDDLE EAST AND OTHERS ORAL APPLIANCES PENETRATION, (2019)
      • FIGURE 161     KEY GROWTH STRATEGIES (2018-2019)
      • FIGURE 162     SWOT: APEX MEDICAL CORPORATION
      • FIGURE 163     SWOT: DRIVE MEDICAL (DRIVE DEVILBISS HEALTHCARE).
      • FIGURE 164     SWOT: FISHER AND PAYKEL HEALTHCARE CORPORATION LIMITED
      • FIGURE 165     SWOT: INSPIRE MEDICAL SYSTEMS INC.
      • FIGURE 166     SWOT: KONINKLIJKE PHILIPS N.V.
      • FIGURE 167     SWOT: NATUS MEDICAL CORPORATION.
      • FIGURE 168     SWOT: NIHON KOHDEN
      • FIGURE 169     SWOT: RESMED INC.,
      • FIGURE 170     SWOT: SOMNOMED
      • FIGURE 171     SWOT: VYAIRE MEDICAL INC.

      LIST OF COMPANIES MENTIONED IN THE REPORT

      • 1     3B MEDICAL INC.
      • 2     ACARE TECHNOLOGY CO., LTD
      • 3     ACTIGRAPH LLC
      • 4     ACURABLE
      • 5     ADVANCED BRAIN MONITORING INC.
      • 6     AIRAVANT MEDICAL
      • 7     AIRING INC.
      • 8     AIRON CORPORATION
      • 9     APEX MEDICAL CORPORATION
      • 10     BEIJING AEONMED
      • 11     BESMED HEALTH BUSINESS
      • 12     BMC MEDICAL CO. LTD
      • 13     BRAEBON MEDICAL CORPORATION
      • 14     BREAS MEDICAL, INC.
      • 15     BREATH WELL MEDICAL SYSTEMS
      • 16     BRYGGS MEDICAL
      • 17     CADWELL INDUSTRIES INC.
      • 18     CAMNTECH LTD
      • 19     CIDELEC
      • 20     CIRCADIANCE LLC.
      • 21     CLEVEMED
      • 22     COMPUMEDICS LIMITED
      • 23     COMFORT ACRYLICS, INC
      • 24     CURATIVE MEDICAL INC.
      • 25     CUSTO MED GMBH
      • 26     DRIVE MEDICAL
      • 27     DYNAFLEX
      • 28     ECTOSENSE
      • 29     FISHER AND PAYKEL HEALTHCARE CORPORATION LTD.,
      • 30     HUNAN BEYOND MEDICAL TECHNOLOGY CO., LTD.
      • 31     HUNAN VENTMED MEDICAL TECHNOLOGY CO., LTD.
      • 32     INSPIRE MEDICAL INC.
      • 33     ITAMAR MEDICAL LTD.,
      • 34     JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.
      • 35     KARE MEDICAL AND ANALYTICAL DEVICES LTD. CO.
      • 36     KEEPMED LTD.
      • 37     KONINKLIJKE PHILIPS N.V.
      • 38     LIVANOVA PLC
      • 39     LÖWENSTEIN MEDICAL GMBH & CO. KG
      • 40     MD MEDICAL INC.
      • 41     MEDICRAFT MEDIKAL SISTEMLER ANONIM ŞIRKETI
      • 42     METRAN CO., LTD.
      • 43     MICOMME MEDICAL TECHNOLOGY DEVELOPMENT CO., LTD.
      • 44     MPOWRX HEALTH & WELLNESS PRODUCTS INC.
      • 45     NATUS MEDICAL INC.
      • 46     NICENEOTECH MEDICAL SYSTEMS
      • 47     NIHON KOHDEN CORPORATION
      • 48     NOX MEDICAL
      • 49     NYXOAH S.A.
      • 50     O-TWO MEDICAL TECHNOLOGIES INC.
      • 51     OVENTUS MEDICAL
      • 52     PANTHERA DENTAL
      • 53     PERLONG MEDICAL EQUIPMENT CO., LTD.
      • 54     PROSMONUS SLEEP TECHNOLOGIES
      • 55     PROVENT SLEEP THERAPY, LLC.
      • 56     RESMED INC.
      • 57     RESONEA INC.
      • 58     RESPICARDIA INC.
      • 59     SEFAM
      • 60     SERVONA GMBH
      • 61     SHENYANG CANTA MEDICAL TECH. CO., LTD.
      • 62     SHENYANG MAX MEDICAL TECHNOLOGY CO., LTD.
      • 63     SLEEPINNOV TECHNOLOGY
      • 64     SLEEPIZ
      • 65     SMART NORA INC.
      • 66     SOMNETICS INTERNATIONAL INC.
      • 67     SOMNOMED
      • 68     VYAIRE MEDICAL INC.
      • 69     WESTMED, INC.
      • 70     WHOLE YOU INC.
      • 71     WIDEMED TECHNOLOGIES LTD.